The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

Joaquin Martinez-Lopez, Satu Mustjoki, Kimmo Porkka, Rebecca B. Klisovic, Dominik Wolf, Lambert Busque, Juan Carlos Hernandez-Boluda, Rene Swanink, Patricia Martin Regueira, Jeffrey H. Lipton

Forskningsoutput: TidskriftsbidragBrevVetenskapligPeer review

Originalspråkengelska
TidskriftLeukemia & lymphoma
Antal sidor4
ISSN1042-8194
DOI
Status!!E-pub ahead of print - 13 feb 2021
MoE-publikationstypA1 Tidskriftsartikel-refererad

Citera det här